Discover 2,007 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,007
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
Location: Miami FL, Dallas TX, Boston MA, Aurora CO, Portland OR
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06942572
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
for
Chronic Kidney Disease Stage 3
Location: Miami FL
Sponsor: AION Healthspan, Inc.
Sex: All
Age: 35 - 70+
Code: NCT06721143
Phase 1, Phase 2, Recruiting
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
for
Non-Small Cell Lung Cancer
Location: Miami FL, Morgantown WV, New York NY
Sponsor: Scientific Institute San Raffaele
Sex: All
Age: 18+
Code: NCT06626243
Recruiting
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
for
Fuchs' Endothelial Dystrophy, Corneal Edema
Location: Miami FL, Indianapolis IN
Sponsor: University of Miami
Sex: All
Age: 18 - 70+
Code: NCT06261346
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CLAD Deconvolved PERG Responses in Glaucoma Patients
for
Glaucoma, Suspect
Location: Miami FL
Sponsor: Jorvec Corp.
Sex: All
Age: 18 - 70+
Code: NCT06388096
Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy